This site is for United States residents 18 years of age or older.

YOU ARE ABOUT TO LEAVE THIS WEBSITE

We're sorry to see you go and we hope you'll come back soon for more information about ICLUSIG® (ponatinib).

Are you sure you want to exit the website?

If you have CML or Ph+ ALL
and you want to learn more,
you've come to the right place.

For people with chronic myeloid leukemia (CML) or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL), who cannot receive any other TKI medicines or have a T315I mutation.

Iclusig logo

FOR CML

Learn about CML and what you may experience with ICLUSIG.

FOR Ph+ ALL

Learn what Ph+ ALL is
and how ICLUSIG can help treat it.

Support when you need it

Takeda Oncology 1Point™ is here to help you access and pay for ICLUSIG, and to answer questions about treatment.

GO TO TAKEDA ONCOLOGY 1POINT

The information provided on this site is intended for informational purposes and cannot replace individualized guidance from a healthcare provider. Be sure to talk with your healthcare provider about making any change to your healthcare regimen. The information on this site is intended for residents of the United States only. Product labeling may be different in other countries.